Browse the corpus

Hepatojugular reflux, also known as abdominojugular reflux, is a classic bedside physical examination maneuver used to assess right-sided cardiac function and systemic venous congestion. A detailed history and physical examination have long served as the cornerstone of diagnosing and managing congestive heart failure (CHF); however, advances in noninvasive imaging over the past few decades have raised questions about the accuracy and clinical value of traditional examination findings.[1][2] Despite these advances, simple bedside maneuvers, such as hepatojugular reflux, remain valuable adjuncts that can enhance diagnostic precision when interpreted in the appropriate clinical context. First described by Pasteur in 1885 as a physical sign associated with tricuspid regurgitation, hepatojugular reflux exploits the hemodynamic response of the right atrium and ventricle to a transient increase in venous return induced by sustained abdominal pressure. In normal physiology, the right ventricle accommodates this preload without a sustained rise in right atrial pressure. In contrast, a positive hepatojugular reflux reflects impaired right ventricular compliance or elevated right-sided filling pressures. Clinically, a positive hepatojugular reflux serves as a meaningful indicator of underlying cardiovascular pathology, most commonly CHF, pulmonary hypertension, and constrictive or restrictive pericardial disease. Beyond its diagnostic role, hepatojugular reflux provides prognostic information in patients with chronic heart failure and can help clinicians estimate volume status and guide therapy. When integrated with careful jugular venous examination and modern imaging modalities, hepatojugular reflux reinforces the importance of high-quality bedside assessment and remains relevant in contemporary cardiovascular practice.

Hepatojugular reflux is a physical examination finding rather than a disease entity and reflects abnormal cardiovascular physiology characterized by impaired right heart accommodation of increased venous return. The fundamental etiology of a positive hepatojugular reflux is elevated right atrial pressure resulting from right ventricular dysfunction or reduced right ventricular compliance. During sustained abdominal compression, venous return from the splanchnic circulation increases. In normal physiology, the right ventricle transiently accommodates this preload without a sustained rise in jugular venous pressure (JVP). In contrast, pathologic states that impair right ventricular filling or forward flow result in a persistent elevation of the JVP, manifesting as a positive hepatojugular reflux. Clinical and hemodynamic studies' results have demonstrated that a positive hepatojugular reflux correlates with multiple cardiac conditions and elevated intracardiac pressures. Some investigations have shown the strongest association with left-sided heart failure, whereas others have demonstrated a closer relationship with right-sided filling pressures.[3][4] Consistently, HJR has been shown to correlate significantly with right atrial pressure, pulmonary capillary wedge pressure (PCWP), pulmonary artery systolic pressure, and pulmonary artery diastolic pressure, supporting its role as a marker of both elevated right- and left-sided filling pressures.[5] Consequently, hepatojugular reflux should not be considered diagnostic of any single disorder but rather an indicator that the right ventricle cannot effectively accommodate an acute increase in venous return. The most common etiologic associations include CHF, particularly advanced left-sided failure complicated by pulmonary hypertension and secondary right ventricular dysfunction. Primary right-sided cardiac disorders—such as right ventricular infarction, severe tricuspid regurgitation, and intrinsic right ventricular cardiomyopathies—frequently produce a positive hepatojugular reflux. Pericardial and myocardial conditions that restrict diastolic filling, including constrictive pericarditis and restrictive cardiomyopathy, are classic causes.

The most common etiologic associations include CHF, particularly advanced left-sided failure complicated by pulmonary hypertension and secondary right ventricular dysfunction. Primary right-sided cardiac disorders—such as right ventricular infarction, severe tricuspid regurgitation, and intrinsic right ventricular cardiomyopathies—frequently produce a positive hepatojugular reflux. Pericardial and myocardial conditions that restrict diastolic filling, including constrictive pericarditis and restrictive cardiomyopathy, are classic causes. Pulmonary vascular disease, including pulmonary hypertension and chronic thromboembolic disease, contributes to sustained right ventricular pressure overload. Left ventricular failure can also produce a positive hepatojugular reflux, typically when PCWP exceeds approximately 15 mm Hg. In contrast, cardiac tamponade does not produce a positive hepatojugular reflux, as external pericardial constraint limits the transmission of increased venous return to the jugular venous system.

The epidemiology of hepatojugular reflux is best understood in the context of the prevalence and burden of the cardiovascular conditions with which it is associated, as it represents a physical examination finding rather than a discrete disease entity. CHF is the condition most commonly linked to a positive hepatojugular reflux, particularly in patients with moderate to severe disease and elevated intracardiac filling pressures. More than 25 million individuals worldwide are affected by CHF, underscoring the global relevance of bedside findings that assist in its diagnosis and management.[6] In the United States, CHF accounts for approximately 1 million hospitalizations annually, with associated healthcare costs approaching $17 billion.[7] Morbidity and mortality remain substantial, with readmission rates exceeding 50% within the first 6 months following hospital discharge.[8][9] Volume overload is the leading cause of heart failure readmissions and may be present at the time of discharge despite apparently adequate medical therapy. In this context, hepatojugular reflux is a simple, noninvasive bedside maneuver that can identify persistent or recurrent volume overload in patients with CHF. Epidemiologic studies evaluating physical examination findings in heart failure populations demonstrate that hepatojugular reflux is frequently present in patients with elevated right atrial pressure, PCWP, and pulmonary artery pressures, particularly during episodes of decompensation. Beyond CHF, hepatojugular reflux is commonly observed in conditions associated with chronic right ventricular pressure or volume overload, including pulmonary hypertension, right ventricular infarction, constrictive pericarditis, and restrictive cardiomyopathy. This finding is uncommon in healthy individuals and in patients with early or well-compensated disease. Still, when present, it has relatively high specificity for elevated intracardiac filling pressures, reinforcing its epidemiologic and clinical importance in populations at high risk for advanced heart failure and complex cardiopulmonary disease.

Deep inspiration generates negative intrathoracic pressure, thereby increasing venous return to the right atrium and subsequently to the right ventricle. This phenomenon in healthy adults enhances blood flow in the right heart chambers and reduces JVP; it is by this mechanism that Carvallo noted that deep inspiration augments right-sided heart murmurs, such as those of tricuspid regurgitation.[10] However, in patients with constrictive pericarditis or right ventricular failure, obstruction of flow in the right-sided chambers results in an elevated JVP. This paradoxical rise in JVP was described by Kussmaul in constrictive pericarditis. As noted by Pasteur, sustained abdominal pressure, similar to the mechanism described above, also increases venous return. This forms the basis of the hepatojugular reflux, in which a sustained elevation of JVP on applying abdominal pressure is used as a marker of right ventricular failure.

The history and physical examination remain fundamental to the evaluation of patients in whom hepatojugular reflux is being assessed, particularly in the context of suspected or established heart failure and other causes of elevated cardiac filling pressures. A focused history should elicit symptoms of volume overload or impaired cardiac reserve, including exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, abdominal distention, early satiety, and unexplained weight gain. Historical features suggesting right-sided involvement include ascites, hepatic congestion–related discomfort, and worsening lower extremity edema. In contrast, left-sided failure is more often associated with pulmonary congestion and reduced exercise tolerance. Past medical history should specifically address ischemic heart disease, cardiomyopathy, valvular disease (particularly tricuspid and mitral pathology), pulmonary hypertension, prior myocardial infarction, pericardial disease, and exposure to cardiotoxic agents. Medication adherence, recent changes in diuretic therapy, dietary sodium intake, and recent hospitalizations for heart failure exacerbations are essential components of the history. The physical examination should be systematic, with particular attention to volume status and signs of elevated right-sided pressures. Assessment of JVP should precede evaluation for hepatojugular reflux, as a markedly elevated baseline JVP may render the maneuver unnecessary. For an accurate assessment, the patient should be positioned.

The physical examination should be systematic, with particular attention to volume status and signs of elevated right-sided pressures. Assessment of JVP should precede evaluation for hepatojugular reflux, as a markedly elevated baseline JVP may render the maneuver unnecessary. For an accurate assessment, the patient should be positioned. Hence, the JVP is clearly visible, classically in a semirecumbent position with the head of the bed elevated 30 to 45 degrees, ensuring at least a 3 cm margin between the upper limit of baseline JVP and the angle of the mandible. A steady abdominal pressure of approximately 20 to 35 mm Hg is then applied for 10 to 15 seconds; although historically applied for 15 seconds, more recent evidence suggests that sustained compression for 10 seconds is sufficient.[11][12] The site of compression does not significantly affect test performance, and direct pressure over the liver is not required; midline abdominal pressure may be preferable to avoid patient discomfort. A sustained rise in JVP greater than 3 cm during compression is considered a positive hepatojugular reflux, while an increase of 1 to 3 cm is regarded as normal. Some clinicians advocate performing the maneuver with the patient fully upright at 90 degrees, positioning the clavicle approximately 10 cm above the right atrium; in this position, sustained JVP elevation above the clavicle for more than 10 seconds is considered abnormal. Additional examination findings that support a pathologic response include hepatomegaly, ascites, peripheral edema, a right ventricular heave, and auscultatory findings such as a tricuspid regurgitation murmur or an accentuated pulmonic component of the second heart sound. Hepatojugular reflux should always be interpreted in the context of the overall clinical examination, as it reflects the inability of the right ventricle to accommodate an acute increase in venous return and serves as a valuable bedside adjunct for assessing hemodynamic congestion rather than a diagnostic test for a single disease entity.

Evaluating a patient with hepatojugular reflux should focus on identifying the underlying cause of elevated cardiac filling pressures and impaired right ventricular compliance. The maneuver itself is a bedside indicator of limited cardiac reserve and should prompt further hemodynamic and structural assessment rather than be viewed as a stand-alone diagnostic test. Evidence from the ESCAPE trial underscored the clinical value of assessing hepatojugular reflux in patients admitted with heart failure, demonstrating high intraobserver agreement (approximately 97%) and a strong correlation with clinical signs of congestion and brain natriuretic peptide levels.[5] Importantly, hepatojugular reflux also correlated with central hemodynamic markers of volume overload, including pulmonary capillary wedge pressure and right atrial pressure.[5] Initial evaluation typically includes laboratory studies, such as natriuretic peptide measurements, to support the diagnosis of heart failure and assess severity, as well as basic metabolic testing to evaluate renal and hepatic congestion. Chest radiography may reveal cardiomegaly, pulmonary edema, or pleural effusions. Echocardiography remains the cornerstone of further evaluation, providing assessment of ventricular function, chamber size, valvular disease, and estimates of right atrial and pulmonary artery pressures. Prior studies' results have demonstrated that hepatojugular reflux is particularly useful in patients presenting with dyspnea, with high specificity—approximately 96%—for diagnosing heart failure when pulmonary capillary wedge pressure is 15 mm Hg or greater.[13] These findings were reaffirmed in subsequent analyses, which also showed that a positive hepatojugular reflux on discharge correlated with higher right atrial pressure, pulmonary artery systolic and diastolic pressures, and increased inferior vena cava diameter, a reliable noninvasive marker of volume status and predictor of decompensated heart failure.[5]

Prior studies' results have demonstrated that hepatojugular reflux is particularly useful in patients presenting with dyspnea, with high specificity—approximately 96%—for diagnosing heart failure when pulmonary capillary wedge pressure is 15 mm Hg or greater.[13] These findings were reaffirmed in subsequent analyses, which also showed that a positive hepatojugular reflux on discharge correlated with higher right atrial pressure, pulmonary artery systolic and diastolic pressures, and increased inferior vena cava diameter, a reliable noninvasive marker of volume status and predictor of decompensated heart failure.[5] Beyond diagnosis, hepatojugular reflux has prognostic implications. Persistent hepatojugular reflux at discharge has been associated with significantly higher 6-month mortality than its resolution (univariate OR: 2.167; 95% CI: 1.189–3.949; P = 0.012).[5]  Outcomes are even poorer when hepatojugular reflux is combined with jugular venous distention, defined as JVP greater than 8 mm Hg. Patients with both findings at discharge had substantially higher 6-month mortality than those with hepatojugular reflux alone (33.8% vs 16.7%; univariate OR: 2.558; 95% CI: 1.023–6.397; P = 0.045).[5] In select cases where noninvasive testing is inconclusive or advanced therapies are being considered, right heart catheterization may be warranted to directly confirm the hemodynamic abnormalities suggested by a positive hepatojugular reflux.

Caring for a patient with a positive hepatojugular reflux is directed at the underlying cause of elevated cardiac filling pressures and impaired ventricular compliance rather than the physical sign itself. In most clinical contexts, this finding reflects volume overload and/or right ventricular dysfunction and should prompt optimization of heart failure therapy. Initial management focuses on careful volume assessment and decongestion, most commonly with loop diuretics, titrated to achieve euvolemia while avoiding renal hypoperfusion and electrolyte disturbances. In patients with persistent congestion, combination diuretic therapy, including thiazide-type agents, may be required. Sodium restriction, fluid management, and daily weight monitoring are essential adjuncts to pharmacologic therapy. For patients with left-sided heart failure, guideline-directed medical therapy should be optimized, including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers or neprilysin inhibitors, beta-blockers, mineralocorticoid receptor antagonists, and sodium–glucose cotransporter-2 inhibitors, as tolerated. Improvement in left ventricular filling pressures often resolves hepatojugular reflux. In patients with right-sided heart failure or pulmonary hypertension, management centers on reducing right ventricular afterload and optimizing preload, which may include pulmonary vasodilator therapy, oxygen supplementation, and careful diuresis. Valvular heart disease, particularly tricuspid regurgitation or mitral valve pathology, should be managed in accordance with current guideline recommendations, as correction of valvular lesions can significantly reduce venous congestion.

For patients with left-sided heart failure, guideline-directed medical therapy should be optimized, including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers or neprilysin inhibitors, beta-blockers, mineralocorticoid receptor antagonists, and sodium–glucose cotransporter-2 inhibitors, as tolerated. Improvement in left ventricular filling pressures often resolves hepatojugular reflux. In patients with right-sided heart failure or pulmonary hypertension, management centers on reducing right ventricular afterload and optimizing preload, which may include pulmonary vasodilator therapy, oxygen supplementation, and careful diuresis. Valvular heart disease, particularly tricuspid regurgitation or mitral valve pathology, should be managed in accordance with current guideline recommendations, as correction of valvular lesions can significantly reduce venous congestion. Patients with constrictive pericarditis or restrictive cardiomyopathy require disease-specific management, such as anti-inflammatory therapy for transient pericardial inflammation or consideration of pericardiectomy in chronic constriction. In ischemic right ventricular failure, revascularization and optimization of coronary perfusion are critical. Importantly, cardiac tamponade does not produce a positive hepatojugular reflux and should be managed separately with urgent pericardial drainage when suspected. The presence of a persistent hepatojugular reflux at discharge identifies a high-risk population with increased mortality and readmission rates and should prompt intensification of therapy, close outpatient follow-up, and patient education focused on early recognition of volume overload. Serial bedside assessment of hepatojugular reflux can be used as a simple, noninvasive tool to monitor response to therapy and guide longitudinal management in patients with heart failure and related hemodynamic disorders.

The differential diagnoses include: Arterial flutter Arterial fibrillation Atrioventricular dissociation Cardiac tamponade Constructive pericarditis First-degree atrioventricular stroke Pulmonary hypertensmyxom Right atrial myxoma Tricuspid stenosis Tricuspid regurgitation

The prognosis associated with a positive hepatojugular reflux is primarily determined by the underlying cardiovascular pathology and the persistence of the finding despite appropriate therapy. In patients with heart failure, a positive hepatojugular reflux reflects elevated cardiac filling pressures and limited ventricular reserve and is consistently associated with more advanced disease, greater degrees of volume overload, and worse short- and intermediate-term outcomes. The presence of this reflux correlates with elevated right atrial pressure, PCWP, and pulmonary artery pressures, all of which are established markers of adverse prognosis in both left- and right-sided heart failure. Importantly, persistence of hepatojugular reflux at hospital discharge has been shown to carry significant prognostic implications. Patients with ongoing hepatojugular reflux at discharge demonstrate higher 6-month mortality compared with those in whom the sign resolves following treatment, with risk further amplified when accompanied by jugular venous distention. This finding suggests incomplete decongestion and identifies a subgroup at high risk for early readmission and death. Conversely, resolution of hepatojugular reflux with therapy is associated with improved hemodynamics and better outcomes, supporting its use as a bedside marker of treatment response. Outside of heart failure, prognosis similarly depends on the reversibility of the underlying condition. In constrictive pericarditis, surgical pericardiectomy can lead to dramatic hemodynamic improvement and resolution of hepatojugular reflux. In contrast, restrictive cardiomyopathy and advanced pulmonary hypertension often carry a poorer prognosis due to limited therapeutic options and progressive right ventricular failure. Overall, hepatojugular reflux should be viewed not as an isolated prognostic factor, but as a clinically meaningful indicator of elevated filling pressures and disease severity. When incorporated into longitudinal assessment, it provides valuable prognostic information and helps guide the intensity of therapy and follow-up in patients with cardiovascular disease.

Hepatojugular reflux is a benign physical examination maneuver and does not directly cause complications when performed correctly. However, the clinical significance of a positive hepatojugular reflux lies in the complications associated with the underlying pathophysiologic states it reflects—namely, elevated cardiac filling pressures and impaired ventricular compliance. Failure to recognize or appropriately act on a positive finding may result in delayed diagnosis or inadequate treatment of decompensated heart failure, right ventricular failure, or constrictive pericardial disease, thereby increasing the risk of adverse clinical outcomes. In patients with heart failure, a persistently positive hepatojugular reflux is associated with complications related to chronic volume overload, including recurrent hospitalizations, progressive ventricular remodeling, worsening renal function due to cardiorenal syndrome, hepatic congestion leading to congestive hepatopathy, and increased risk of arrhythmias. Elevated right-sided pressures reflected by a positive hepatojugular reflux can also contribute to ascites, peripheral edema, and impaired gastrointestinal absorption of medications, complicating medical management and limiting therapeutic effectiveness. From a procedural and diagnostic standpoint, misinterpretation of the hepatojugular reflux can lead to inappropriate clinical decisions. False-positive findings may occur if the maneuver is performed incorrectly or in patients with abdominal discomfort or increased intraabdominal pressure, potentially leading to unnecessary escalation of diuretic therapy and resultant hypotension or renal injury. Conversely, false-negative assessments may delay recognition of persistent congestion, exposing patients to higher risks of early readmission and mortality. Therefore, while the maneuver itself is low risk, the downstream complications of unrecognized or mismanaged hemodynamic congestion underscore the importance of proper technique, contextual interpretation, and integration with the overall clinical assessment.

Deterrence and patient education play an important role in the clinical utility of the hepatojugular reflux by addressing the underlying conditions that lead to abnormal findings, rather than the maneuver itself. Patients with heart failure or other causes of elevated filling pressures should be educated on strategies that deter recurrent volume overload, which is the most common driver of a persistently positive hepatojugular reflux. Education should emphasize adherence to guideline-directed medical therapy, dietary sodium restriction, fluid management when indicated, and consistent use of prescribed diuretics. Patients should also be taught to recognize early warning signs of congestion—such as rapid weight gain, increasing lower extremity edema, abdominal distention, or worsening dyspnea—and to seek medical attention before progression to overt decompensation. Clinicians should incorporate patient education into discharge planning and longitudinal follow-up, reinforcing the relationship between lifestyle choices and hemodynamic status. Counseling on medication adherence, avoidance of nonsteroidal anti-inflammatory drugs, moderation of alcohol intake, and smoking cessation can reduce exacerbations of heart failure and prevent recurrent hospitalizations. For patients with advanced disease, structured self-monitoring programs that include daily weight measurements and symptom diaries can reduce late presentation with severe congestion. By improving patient understanding of the pathophysiology of volume overload and its clinical consequences, education serves as a preventive strategy that supports early intervention, reduces complications, and enhances long-term outcomes in conditions in which hepatojugular reflux is a clinically meaningful sign.

With the rapid advancements being made in diagnostic tools, including imaging or invasive tests, for detection of heart failure, there has been reduced emphasis on physical examination skills. The hepatojugular reflux is a very simple and useful bedside test that can diagnose right heart failure. Performance of the test has been described earlier in the manuscript. We encourage residents and physicians to routinely perform a detailed physical examination including hepatojugular reflux, which can help diagnose or rule out right heart failure.

Optimal use of hepatojugular reflux as a clinical tool depends on disciplined bedside skills, deliberate diagnostic strategy, and consistent interprofessional communication. Physicians and advanced practitioners must apply standardized techniques and interpret hepatojugular reflux in conjunction with jugular venous pressure, symptoms, laboratory data, and imaging to assess intravascular volume and cardiac filling pressures accurately. Incorporating hepatojugular reflux into routine cardiovascular examinations—particularly during admission and before discharge in patients with heart failure—supports earlier detection of persistent congestion and more precise titration of therapy. Nurses play a critical role through serial bedside assessments, early recognition of changes in venous congestion, and timely communication of abnormal findings that may indicate evolving decompensation, thereby directly enhancing patient safety. Effective care coordination ensures that hepatojugular reflux findings translate into patient-centered management rather than isolated observations. Pharmacists support team performance by optimizing diuretic strategies, identifying medications that exacerbate volume overload, and reinforcing adherence and monitoring plans. Advanced practice providers and case managers coordinate follow-up care, ensuring continuity of care and reinforcing education on sodium restriction, daily weight monitoring, and symptom surveillance. Clear, closed-loop communication among bedside clinicians, heart failure teams, and outpatient providers aligns physical examination findings with hemodynamic goals and discharge planning. This collaborative, nonhierarchical approach improves outcomes, reduces avoidable readmissions, and reinforces hepatojugular reflux as a shared, actionable marker of congestion across the continuum of care.